Archives for December 20, 2005

← 2005

DOV announces second Phase I trial for depression drug

By  Wai Lang Chu

DOV Pharmaceutical has announced the initiation of a Phase Ib clinical trial, which investigates the potential of its triple reuptake inhibitor candidate for treating depression. The drug's mechanism of action inhibits three separate neurotransmitters...